ABEONA THERAPEUTICS INC. — Director's Dealing 2014

Dec 29, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLASMATECH BIOPHARMACEUTICALS INC (PTBI)
CIK: 0000318306
Period of Report: 2014-12-24

Reporting Person: Jeffrey B Davis (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-24	Common Stock	P	62500	$4	Acquired	67858	Indirect
2014-12-24	Common Stock	J	594801	$4	Acquired	662659	Indirect
2014-12-24	Common Stock	J	300852	$4	Acquired	963511	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-12-24	Common Stock Purchase Warrants	$5	P	62500	Acquired	2019-12-24	Common Stock (62500)	Indirect
2014-12-24	Series A Cumulative Convertible Preferred Stock	$4	C	237.9205	Disposed	2014-12-24	Common Stock (594801)	Indirect

Footnotes

F1: Jeffrey B. Davis is the managing member of Lake End Capital LLC

F2: Series A Cumulative Convertible Preferred Stock was converted by the Company into common stock on 12/24/2014.

F3: Series A Preferred Stock dividends due and interest due on dividends and liquidated damages were converted into common stock by the company on 12/24/2014.